Pure Global

Eye drop solution - Vietnam Registration 240002596/PCBB-HCM

Access comprehensive regulatory information for Eye drop solution in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TBYT Loại B medical device is registered under number 240002596/PCBB-HCM and manufactured by CÔNG TY CỔ PHẦN LIÊN DOANH CÔNG NGHỆ DƯỢC PHẨM VIỆT Ý. The authorized representative in Vietnam is CÔNG TY TNHH ĐẦU TƯ VÀ PHÁT TRIỂN VẠN TAM.

This page provides complete technical specifications, regulatory compliance details, 5 companies making similar products including CÔNG TY CỔ PHẦN LIÊN DOANH CÔNG NGHỆ DƯỢC PHẨM VIỆT Ý, DCareme Co., Ltd., and 5 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
5 Competitors
5 Recent Registrations
240002596/PCBB-HCM
Registration Details
Vietnam MOH Registration: 240002596/PCBB-HCM
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Eye drop solution
VN: Dung dịch nhỏ mắt
DR.OSCAROTO
Risk Class TBYT Loại B

Registration Details

240002596/PCBB-HCM

000.00.19.H29-241110-0002

01

Company Information

CÔNG TY TNHH ĐẦU TƯ VÀ PHÁT TRIỂN VẠN TAM

Technical Details

- Dr.Oscaroto helps to lubricate and restore the normal physiological state of the eye, alleviating discomfort caused by external environmental factors such as smoke, rain, etc., which can lead to eye pain, fatigue, blurred vision, and dryness. It helps the eye to feel more comfortable and quickly recover its normal physiological function, thereby improving vision. - Sodium hyaluronate, an ingredient in Dr.Oscaroto, is considered a form of artificial tears that can replace the function of the mucin in tears when the eye is unable to produce tears normally, as in cases of surgery, age-related changes, or damage to the tear gland, creating a protective layer that reduces water evaporation and stimulates the growth of new cells in the conjunctiva and cornea, as well as the body's natural healing processes.

Dates and Status

Nov 15, 2024